Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
4.200
-0.020 (-0.47%)
May 9, 2025, 10:47 AM - Market open
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $258.34 million as of May 9, 2025. Its market cap has decreased by -7.00% in one year.
Market Cap
258.34M
Enterprise Value
-24.64M
1-Year Change
-7.00%
Ranking
Category
Stock Price
$4.20
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has decreased from $845.31M to $258.34M, a decrease of -69.44%. That is a compound annual growth rate of -26.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 259.57M | -39.12% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.29B |
| Johnson & Johnson | 378.48B |
| UnitedHealth Group | 355.95B |
| AbbVie | 332.73B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.05B |
| Novartis AG | 218.96B |
| AstraZeneca | 217.30B |